Clinical trial
Impact of TB Preventive Therapy for HIV/TB Co-infected Patients With Access to Highly Active Antiretroviral Therapy in Rio de Janeiro, Brazil: A Phased Implementation Trial
NCT00107887 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of TB Preventive Therapy for HIV/TB Co-infected Patients With Access to Highly Active Antiretroviral Therapy in Rio de Janeiro, Brazil: A Phased Implementation Trial
- Lead sponsor
- Johns Hopkins University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2005
- Completion date
- December 31, 2010
- Enrollment
- 17,415 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.